Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Delta Opioid Receptor Gene (OPRD1) Variations on Treatment Outcome in African Americans

NCT02225184 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.

NCT NCT02225184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02225184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Delta Opioid Receptor Gene (OPRD1) Variations on Treatment Outcome in African Americans
Lead sponsor
National Institute on Drug Abuse (NIDA)
Phase
Observational
Overall status
Completed
Start date
August 23, 2014
Completion date
December 31, 2018
Enrollment
81 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug abuse/dependence, genetic underpinning of substance abuse, opiod-related disorders, polymorphism-genetic